Dapagliflozin Reduces CV Death, Heart Failure Worsening in HFpEF Patients
The placebo-controlled, event-driven DELIVER study included 6263 patients.
Diana Ernst, RPh
Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.
